HDL-Mediated Cholesterol Efflux Associates with Incident Kidney Disease
Clin Chem
.
2021 Mar 31;67(4):689-691.
doi: 10.1093/clinchem/hvab024.
Authors
Sanna Kuusisto
1
2
3
,
Christina Kostara
4
,
Antti J Kangas
5
,
Markus Perola
6
7
8
,
Veikko Salomaa
6
,
Johannes Kettunen
1
2
6
,
Mika Ala-Korpela
1
2
3
Affiliations
1
Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
2
Center for Life Course Health Research, University of Oulu, Oulu, Finland.
3
NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
4
Laboratory of Clinical Chemistry, School of Medicine, University of Ioannina, Ioannina, Greece.
5
Nightingale Health Ltd., Helsinki, Finland.
6
Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.
7
Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland.
8
Estonian Genome Center, University of Tartu, Tartu, Estonia.
PMID:
33723592
DOI:
10.1093/clinchem/hvab024
No abstract available
MeSH terms
Biological Transport
Cholesterol, HDL* / metabolism
Humans
Kidney Diseases* / epidemiology
Lipoproteins, HDL / metabolism
Substances
Cholesterol, HDL
Lipoproteins, HDL